The Fracture Risk Assessment Tool (FRAX) was developed by the World Health Organization (WHO) task force in 2008 to provide a prediction tool for assessing an individualâ€™s risk of fracture in order to provide general clinical guidance for treatment decisions. FRAX was motivated by a desire to incorporate non-BMD clinical risk factors into the assessment of a patient's fracture risk, and therefore risk can be calculated with or without knowledge of BMD. When BMD is entered, FRAX uses the BMD of the femoral neck, in addition to the other validated clinical risk factors, to estimate risk and probability of fracture in the next 10 years in untreated patients ages 40 to 90 years of age. Of note, this tool has been validated using BMD at the hip only and is not validated using other areas, such as the spine. Thresholds for pharmacologic treatment, willingness to pay, and fracture related costs will vary from country to country.
Click here to access the Fracture Risk Assessment Tool (FRAX).
Be sure to pick a country under Calculation Tool after you access the FRAX tool: